Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
125.21
+0.39 (0.31%)
Nov 5, 2024, 2:15 PM EST - Market open
Revvity Revenue
Revvity had revenue of $684.05M in the quarter ending September 29, 2024, with 1.98% growth. This brings the company's revenue in the last twelve months to $2.72B, down -2.66% year-over-year. In the year 2023, Revvity had annual revenue of $2.75B, down -16.95%.
Revenue (ttm)
$2.72B
Revenue Growth
-2.66%
P/S Ratio
5.65
Revenue / Employee
$236,657
Employees
11,500
Market Cap
15.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Dec 28, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.97B |
Viatris | 15.24B |
Avantor | 6.82B |
Incyte | 4.08B |
Align Technology | 3.96B |
United Therapeutics | 2.76B |
Genmab | 2.73B |
Insulet | 1.87B |
RVTY News
- 1 day ago - Revitty (RVTY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
- 1 day ago - Revvity Announces Financial Results for the Third Quarter of 2024 - Business Wire
- 11 days ago - Revvity Board Declares Quarterly Dividend - Business Wire
- 14 days ago - Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories - Business Wire
- 14 days ago - Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report - Business Wire
- 4 weeks ago - Revvity To Hold Earnings Call on Monday, November 4, 2024 - Business Wire
- 4 weeks ago - Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene - Business Wire